Case Study

Case Study: CryoPort Turns To Cloud Computing To Develop Tomorrow's New Vaccines

James Staten
 and  two contributors
Sep 09, 2009

Summary

New-vaccine and pharmaceutical delivery is a very time-sensitive application to say the least, especially when uncertainty can skew test results. CryoPort and KLATU Networks teamed up to build a biological package tracking system that leveraged Amazon Web Services' Elastic Compute Cloud (EC2) to eliminate shipping and storage uncertainty from pharmaceutical transport — and do so at scale. This unique system aggregates all the necessary shipping, customs forms, and temperature logs throughout the packages' journey so the receiving hospital can be confident that the vaccines and pharmaceuticals were handled properly and remain viable for use. By leveraging cloud computing, KLATU can confidently state that the system will be able to scale to more than 40 million shipments per year and thousands of simultaneous users.

Log in to continue reading
Client log in
Welcome back. Log in to your account to continue reading this research.
Become a client
Become a client today for these benefits:
  • Stay ahead of changing market and customer dynamics with the latest insights.
  • Partner with expert analysts to make progress on your top initiatives.
  • Get answers from trusted research using Izola, Forrester's genAI tool.
Purchase this report
This report is available for individual purchase ($1495).